Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses

被引:19
|
作者
Anderson, Ariana E. [1 ,2 ]
Marder, Stephen [1 ]
Reise, Steven P. [3 ]
Savitz, Adam [4 ]
Salvadore, Giacomo [4 ]
Fu, Dong Jing [4 ]
Li, Qingqin [4 ]
Turkoz, Ibrahim [4 ]
Han, Carol [1 ]
Bilder, Robert M. [1 ,3 ]
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA
[4] Janssen Res & Dev, Titusville, NJ USA
基金
美国国家卫生研究院;
关键词
PANSS; bifactor model; schizophrenia; schizoaffective; bipolar disorder; PALIPERIDONE EXTENDED-RELEASE; SUBSTANCE USE DISORDERS; DOUBLE-BLIND; TRANSDIAGNOSTIC FACTORS; PSYCHOPATHOLOGY FACTOR; 5-FACTOR MODEL; TABLETS; SYMPTOMS; EFFICACY; SAFETY;
D O I
10.1093/schbul/sbx163
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Common genetic variation spans schizophrenia, schizoaffective and bipolar disorders, but historically, these syndromes have been distinguished categorically. A symptom dimension shared across these syndromes, if such a general factor exists, might provide a clearer target for understanding and treating mental illnesses that share core biological bases. Method: We tested the hypothesis that a bifactor model of the Positive and Negative Syndrome Scale (PANSS), containing 1 general factor and 5 specific factors (positive, negative, disorganized, excited, anxiety), explains the cross-diagnostic structure of symptoms better than the traditional 5-factor model, and examined the extent to which a general factor reflects the overall severity of symptoms spanning diagnoses in 5094 total patients with a diagnosis of schizophrenia, schizoaffective, and bipolar disorder. Results: The bifactor model provided superior fit across diagnoses, and was closer to the "true" model, compared to the traditional 5-factor model (Vuong test; P < .001). The general factor included high loadings on 28 of the 30 PANSS items, omitting symptoms associated with the excitement and anxiety/depression domains. The general factor had highest total loadings on symptoms that are often associated with the positive and disorganization syndromes, but there were also substantial loadings on the negative syndrome thus leading to the interpretation of this factor as reflecting generalized psychosis. Conclusions: A bifactor model derived from the PANSS can provide a stronger framework for measuring cross-diagnostic psychopathology than a 5-factor model, and includes a generalized psychosis dimension shared at least across schizophrenia, schizoaffective, and bipolar disorder.
引用
收藏
页码:1204 / 1216
页数:13
相关论文
共 50 条
  • [21] Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia
    Lim, Keane
    Peh, Oon-Him
    Yang, Zixu
    Rekhi, Gurpreet
    Rapisarda, Attilio
    See, Yuen-Mei
    Rashid, Nur Amirah Abdul
    Ang, Mei-San
    Lee, Sara-Ann
    Sim, Kang
    Huang, Hailiang
    Lencz, Todd
    Lee, Jimmy
    Lam, Max
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 62
  • [22] Resolving "Deficit'' and "Distress'' Schizophrenia Subgroups from Positive and Negative Syndrome Scale Data
    Dickinson, Dwight
    Pratt, Danielle
    Orel, Jennifer
    Giangrande, Evan
    Weinberger, Daniel R.
    Berman, Karen
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S405 - S405
  • [23] Are Ratings on the Positive and Negative Syndrome Scale for Schizophrenia Biased by Personality Traits?
    Huber, C. G.
    Hoppe, A.
    Agorastos, A.
    Andresen, B.
    Naber, D.
    Schroeder, K.
    PHARMACOPSYCHIATRY, 2012, 45 (04) : 156 - 161
  • [24] Structural Differences within Negative and Depressive Syndrome Dimensions in Schizophrenia, Organic Brain Disease, and Major Depression: A Confirmatory Factor Analysis of the Positive and Negative Syndrome Scale
    Eisenberg, Daniel P.
    Aniskin, Dmitry B.
    White, Leonard
    Stein, Judith A.
    Harvey, Philip D.
    Galynker, Igor I.
    PSYCHOPATHOLOGY, 2009, 42 (04) : 242 - 248
  • [25] Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study
    Citrome, Leslie
    Risinger, Robert
    Cutler, Andrew J.
    Du, Yangchun
    Zummo, Jacqueline
    Nasrallah, Henry A.
    Silverman, Bernard L.
    CNS SPECTRUMS, 2018, 23 (04) : 284 - 290
  • [26] Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
    Todd S. Woodward
    Kwanghee Jung
    Geoffrey N. Smith
    Heungsun Hwang
    Alasdair M. Barr
    Ric M. Procyshyn
    Sean W. Flynn
    Mark van der Gaag
    William G. Honer
    European Archives of Psychiatry and Clinical Neuroscience, 2014, 264 : 673 - 682
  • [27] Validated five-factor model of Positive and Negative Syndrome Scale for schizophrenia in Chinese population
    Jiang, Jundong
    Sim, Kang
    Lee, Jimmy
    SCHIZOPHRENIA RESEARCH, 2013, 143 (01) : 38 - 43
  • [28] Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale
    Reddy, Venkatesh Pilla
    Kozielska, Magdalena
    Johnson, Martin
    Mafirakureva, Nyashadzaishe
    Vermeulen, An
    Liu, Jing
    de Greef, Rik
    Rujescu, Dan
    Groothuis, Geny M. M.
    Danhof, Meindert
    Proost, Johannes H.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (06) : 731 - 739
  • [29] Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores
    Ismail, Zahinoor
    Peters-Strickland, Timothy
    Miguelez, Maia
    Baker, Ross A.
    Hertel, Peter
    Eramo, Anna
    Jin, Na
    Perry, Pamela
    Sanchez, Raymond
    McQuade, Robert D.
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (03) : 347 - 350
  • [30] Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis
    Yang, Zixu
    Lim, Keane
    Lam, Max
    Keefe, Richard
    Lee, Jimmy
    SCHIZOPHRENIA RESEARCH, 2018, 201 : 85 - 90